Billie Bonevski is qualified as a Behavioural Scientist (University of Newcastle) and is a Matthew Flinders Professor of Public Health with 25 years experience in health and medical research leadership. 

Following her PhD she spent a year at Oxford University on a WHO-funded fellowship at the Imperial Cancer Research Fund and Cochrane Collaboration Tobacco Addiction Review Group. Billie has been a research fellow (Cancer Institute NSW and NHMRC funded) and research leader (Women in Science Chair, University of Newcastle).

Billie's research interests are broad, committed to working with consumers, stakeholders and the community for preventing disease, improving health care and reducing health disparities. In particular, she and her team are internationally recognised for their tobacco control and smoking cessation research and impact.  She has won institutional, national and international awards for research excellence, supervision and mentorship, and leadership and service.  She contributes to a range of health policy forums.

As a Chief Investigator on 33 NHMRC and MRFF grants, CIA on 10 of these, her research program has had continuous NHMRC funding for the last 15 years. In total, she has attracted over $69 million in research funding as CI, mainly in Category 1 grants. In 2021, she was part of an international consortia awarded an NHMRC Centre of Research Excellence for Achieving the Tobacco Endgame (CIB and co-Director).

She has published 280+ peer-reviewed articles, 77% in Q1 journals, and one in four of her papers include international co-authors. Her highly cited research has led to methodological advancements, influenced national health policy and informed program delivery in community-based health services with substantial impact. 

• Behavioural Science (13)